Treatment Approach for MSI-H/dMMR CRC
ASCO 2021 Update on Pembrolizumab vs. Chemo in MSI-H/dMMR mCRC: Final OS Results From the KEYNOTE-177 Trial
By
ecancer
FEATURING
Thierry André
By
ecancer
FEATURING
Thierry André
Login to view comments.
Click here to Login
Treatment Approach for MSI-H/dMMR CRC